TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

Gain the skills, dexterity and confidence to propel your career into senior management. Whether the goal is to create a standalone solution or fashion part of a complex talent development initiative, ...